BioCentury
ARTICLE | Company News

Biogen Idec, Cardiokine deal

July 9, 2007 7:00 AM UTC

BIIB and Cardiokine partnered to develop and commercialize Cardiokine's lixivaptan to treat hyponatremia. Cardiokine will receive $50 million up front and is eligible for $170 million in milestones, ...